SANDOZ APREMILAST
Identification of Sandoz Apremilast
No description |
Google image searchProduct monograph
Active ingredient
apremilast, 30 MG
DIN: 02529084
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: SANDOZ CANADA INCORPORATED
Date: 18-NOV-2022
ATC:
- L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
- L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
- L04AA — Selective immunosuppressants (ATC, ATC/DDD)
- L04AA32 — APREMILAST (ATC/DDD)
External Links for Sandoz Apremilast
Search on Google
Sandoz Canada Incorporated
Go to Sandoz website to see drug product details. Sometimes you can find sandoz apremilast photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.